Financials

News Discussions Technicals Forecast Seasonals

C43 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to COSMO PHARMA N.V. operating, investing, and financing activities

C43 free cash flow for H1 24 is 93.59 M CHF. For 2023, C43 free cash flow was 25.97 M CHF and operating cash flow was 29.22 M CHF.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: CHF

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—